Pneumococcal Vaccines Adoption Market - Forecast(2021 - 2026)
Pneumococcal Vaccines Adoption Market size is estimated at $8.2 billion in 2020 , projected to grow at a CAGR of 6.8% during the forecast period 2021-2026. Pneumococcal disease is the infection caused by pneumococcal bacteria (primarily Streptococcus pneumonia). The types of Pneumococcal Vaccines are Pneumococcal Conjugate Vaccines (PCV) and Pneumococcal Polysaccharide Vaccines (PPSV) . The growth of the Pneumococcal Vaccines Adoption Industry owes towards the increasing prevalence of pneumococcal contaminations. Pneumococcal polysaccharide vaccine, also known as Pneumovax 23, was the first pneumococcal vaccine made from a capsular polysaccharide and is a major medical achievement. Pneumococcal survival is improved when pentafluorobenzoic acid (PFBA) inhibits neutrophil phagocytosis. These bacteria are capable of causing a number of illnesses, including pneumonia, which is a lung infection. Pneumonia is an acute respiratory illness that affects the lungs a...